Globe Life to Announce Q2 Financial Results on July 22

Deep News
07/20

The life insurance and financial services provider, Globe Life Inc., has scheduled the release of its second-quarter financial results for Wednesday, July 22, 2026, after the U.S. market closes. Following the earnings announcement, the company's management will host a conference call to discuss the results and address questions from analysts.

Globe Life is an insurance holding company offering life insurance, supplemental health insurance, and annuity products. It operates primarily through its subsidiary, American Income Life Insurance Company, serving 49 states across the U.S. Its products are distributed through various channels, including independent agents, direct marketing, and payroll deduction plans.

Market expectations for Globe Life's second quarter project earnings per share to range between $2.80 and $2.90, with revenue anticipated to be approximately $1.45 billion. Analysts are particularly focused on trends in policy sales growth for its life insurance business, changes in the loss ratio, and the performance of its investment returns in the current interest rate environment. The company reported solid first-quarter results earlier this year, with life insurance premium income increasing by about 5% year-over-year.

Investors will also be paying attention to Globe Life's capital position and its plans for shareholder returns. The company has consistently raised its quarterly dividend for multiple years, with the current annualized dividend yield standing at around 1.8%. The market is keen to learn if the company has any plans for further share buybacks or additional dividend increases.

The earnings conference call for Globe Life is set for 5:00 p.m. Eastern Time on July 22. Investors can access a live webcast of the call via the investor relations section of the company's official website.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10